250 related articles for article (PubMed ID: 16866776)
1. Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer.
Kinnunen K; Korpisalo P; Rissanen TT; Heikura T; Viita H; Uusitalo H; Ylä-Herttuala S
Acta Physiol (Oxf); 2006 Aug; 187(4):447-57. PubMed ID: 16866776
[TBL] [Abstract][Full Text] [Related]
2. Baculovirus is an efficient vector for the transduction of the eye: comparison of baculovirus- and adenovirus-mediated intravitreal vascular endothelial growth factor D gene transfer in the rabbit eye.
Kinnunen K; Kalesnykas G; Mähönen AJ; Laidinen S; Holma L; Heikura T; Airenne K; Uusitalo H; Ylä-Herttuala S
J Gene Med; 2009 May; 11(5):382-9. PubMed ID: 19263462
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.
Vajanto I; Rissanen TT; Rutanen J; Hiltunen MO; Tuomisto TT; Arve K; Närvänen O; Manninen H; Räsänen H; Hippeläinen M; Alhava E; Ylä-Herttuala S
J Gene Med; 2002; 4(4):371-80. PubMed ID: 12124979
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.
Rutanen J; Rissanen TT; Markkanen JE; Gruchala M; Silvennoinen P; Kivelä A; Hedman A; Hedman M; Heikura T; Ordén MR; Stacker SA; Achen MG; Hartikainen J; Ylä-Herttuala S
Circulation; 2004 Mar; 109(8):1029-35. PubMed ID: 14967735
[TBL] [Abstract][Full Text] [Related]
5. Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer.
Rota R; Riccioni T; Zaccarini M; Lamartina S; Gallo AD; Fusco A; Kovesdi I; Balestrazzi E; Abeni DC; Ali RR; Capogrossi MC
J Gene Med; 2004 Sep; 6(9):992-1002. PubMed ID: 15352072
[TBL] [Abstract][Full Text] [Related]
6. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.
Huusko J; Merentie M; Dijkstra MH; Ryhänen MM; Karvinen H; Rissanen TT; Vanwildemeersch M; Hedman M; Lipponen J; Heinonen SE; Eriksson U; Shibuya M; Ylä-Herttuala S
Cardiovasc Res; 2010 Apr; 86(1):122-30. PubMed ID: 19955220
[TBL] [Abstract][Full Text] [Related]
7. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
8. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
9. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis.
Rissanen TT; Korpisalo P; Markkanen JE; Liimatainen T; Ordén MR; Kholová I; de Goede A; Heikura T; Gröhn OH; Ylä-Herttuala S
Circulation; 2005 Dec; 112(25):3937-46. PubMed ID: 16344386
[TBL] [Abstract][Full Text] [Related]
10. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.
Askari A; Unzek S; Goldman CK; Ellis SG; Thomas JD; DiCorleto PE; Topol EJ; Penn MS
J Am Coll Cardiol; 2004 May; 43(10):1908-14. PubMed ID: 15145120
[TBL] [Abstract][Full Text] [Related]
11. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.
Mori K; Gehlbach P; Ando A; McVey D; Wei L; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2428-34. PubMed ID: 12091447
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism.
Rutanen J; Turunen AM; Teittinen M; Rissanen TT; Heikura T; Koponen JK; Gruchala M; Inkala M; Jauhiainen S; Hiltunen MO; Turunen MP; Stacker SA; Achen MG; Ylä-Herttuala S
Gene Ther; 2005 Jun; 12(12):980-7. PubMed ID: 15759018
[TBL] [Abstract][Full Text] [Related]
13. Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy.
Korpisalo P; Hytönen JP; Laitinen JT; Laidinen S; Parviainen H; Karvinen H; Siponen J; Marjomäki V; Vajanto I; Rissanen TT; Ylä-Herttuala S
Eur Heart J; 2011 Jul; 32(13):1664-72. PubMed ID: 21138938
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal adenoviral 15-lipoxygenase-1 gene transfer prevents vascular endothelial growth factor A-induced neovascularization in rabbit eyes.
Viita H; Kinnunen K; Eriksson E; Lähteenvuo J; Babu M; Kalesnykas G; Heikura T; Laidinen S; Takalo T; Ylä-Herttuala S
Hum Gene Ther; 2009 Dec; 20(12):1679-86. PubMed ID: 19694557
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
Edelman JL; Lutz D; Castro MR
Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model.
Rissanen TT; Markkanen JE; Arve K; Rutanen J; Kettunen MI; Vajanto I; Jauhiainen S; Cashion L; Gruchala M; Närvänen O; Taipale P; Kauppinen RA; Rubanyi GM; Ylä-Herttuala S
FASEB J; 2003 Jan; 17(1):100-2. PubMed ID: 12475908
[TBL] [Abstract][Full Text] [Related]
17. Intraocular gutless adenoviral-vectored VEGF stimulates anterior segment but not retinal neovascularization.
Oshima Y; Takahashi K; Oshima S; Saishin Y; Saishin Y; Silva RL; Liang X; Reddy PS; Ganesh S; Brann T; Liau G; Kaleko M; Connelly S; Campochiaro PA
J Cell Physiol; 2004 Jun; 199(3):399-411. PubMed ID: 15095287
[TBL] [Abstract][Full Text] [Related]
18. AdVEGF165 gene transfer increases survival in overdimensioned skin flaps.
Giunta RE; Holzbach T; Taskov C; Holm PS; Konerding MA; Schams D; Biemer E; Gänsbacher B
J Gene Med; 2005 Mar; 7(3):297-306. PubMed ID: 15515117
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state.
Schalch P; Rahman GF; Patejunas G; Goldschmidt RA; Carbray J; Retuerto MA; Kim D; Esser K; Crystal RG; Rosengart TK
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):535-40. PubMed ID: 14762365
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.
Lähteenvuo JE; Lähteenvuo MT; Kivelä A; Rosenlew C; Falkevall A; Klar J; Heikura T; Rissanen TT; Vähäkangas E; Korpisalo P; Enholm B; Carmeliet P; Alitalo K; Eriksson U; Ylä-Herttuala S
Circulation; 2009 Feb; 119(6):845-56. PubMed ID: 19188502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]